Mometasonfuroaat Bpm (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Bpm, is a corticosteroid presented as a nasal spray formulation for nasal use. It is employed to manage inflammatory nasal conditions such as allergic rhinitis and nasal polyps in adults and children. It is indicated for patients requiring local anti‑inflammatory therapy to relieve nasal symptoms and improve airway patency.

GNH USA supplies Mometasonfuroaat Bpm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. Nasal polyps: decreases polyp size and improves nasal airflow after surgical removal. Non‑allergic rhinitis: alleviates chronic nasal irritation and discharge.

Mometasone furoate nasal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning - Dryness of nasal passages - Headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Nasal candidiasis - Glaucoma or cataract development with long‑term use

Before using Mometasonfuroaat Bpm, consider the following precautions.

Pregnancy: consult a healthcare provider before use. Pediatric use: safety not established in children under 2 years. Concurrent nasal surgery: avoid use immediately before or after procedures. Long‑term therapy: monitor for signs of increased ocular pressure. Store at room temperature: keep in original packaging, protect from moisture and heat.

Mometasone furoate may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live intranasal vaccines: reduced vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance nasal dryness. - Decongestant nasal sprays: concurrent use may increase irritation. - Antifungal nasal agents: potential additive local effects.